Abstract PS5-07-11: A phase 1 study of LY4257496, a novel GRPR-targeted radioligand therapy, in patients with GRPR-positive metastatic ER+ breast cancer and other advanced solid tumors - OMNIRAY (Trial in Progress)

已取消 20 由 Lilian 发布于 2026/5/8 13:36:34

DOI:10.1158/1557-3265.sabcs25-ps5-07-11
作者：K. Jhaveri, L. Bodei, P. Bedard, K. Jerzak, D. Juric, J. O'Shaughnessy, E. Mayer, N. Harbeck, H. Rugo, A. Bardia, P. Veit-Haibach, P. Heidari, V. Prasad, K. Herrmann, C. Trieu, F. Almaguel
文献类型：期刊论文
补充材料：只需要正文
管理员驳回:超时未应助，系统关闭。如求助信息不完整（标题、DOI、原文链接），可以补充后重新发布求助。

American Association for Cancer Research (AACR)

Abstract：Background: Gastrin-releasing peptide receptor (GRPR) is a G protein-coupled receptor overexpressed in estrogen receptor-positive (ER+) breast cancers (BC) and other solid tumors.1 LY4257496

应助信息

2026-05-08

Book学术机器人

2026/5/8 13:36:34 未找到该文献，机器人已退出，请等待人工下载

2026/5/8 13:36:34 Book学术AI机器人收到请求，开始寻找文献

2026/5/8 13:36:34 已向机器人发送请求

2026-05-08

Lilian 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Photoredox-Catalyzed Cyclopropanation via Ligated Boryl Radical-Mediated Nonstabilized Carbene Formation